Keyphrases
Laparoscopic Pyeloplasty
90%
Adrenal Mass
75%
Renal Stone
75%
Erectile Dysfunction
68%
Lower Pole
60%
Mini-percutaneous Nephrolithotomy
60%
Lithotripsy
60%
Kidney
56%
Percutaneous Nephrolithotomy
51%
Metastasis
49%
Microperc
45%
Peripheral Blood Counts
45%
Micropercutaneous
45%
Inflatable Penile Prosthesis
45%
Two-piece
45%
Upper Urinary Tract
45%
University Experience
45%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
45%
Hyperbilirubinemia
45%
Paraneoplastic
45%
Papillary Renal Cell Carcinoma (pRCC)
45%
Antegrade Stent
45%
Cholestasis
45%
Solitary Adrenal Metastasis
45%
Nebivolol
45%
Nephroureterectomy
45%
Situs Inversus Totalis
45%
Rabbit Corpus Cavernosum
45%
Non-cholinergic
45%
Randomized Placebo-controlled Trial
45%
Nephrostomy
45%
Postoperative Pain Management
45%
Local Anesthetics
45%
Age-based
45%
Renal Pelvicalyceal System
45%
Testicular Cancer
45%
All-seeing Needle
45%
Common Bile Duct
45%
Neutrophil-to-lymphocyte Ratio
45%
Trocar
45%
Infiltration
45%
Holmium Laser
45%
Patient Satisfaction Score
45%
Stent
45%
Asymmetric Dimethylarginine
45%
Overall Satisfaction
45%
In Vitro Evaluation
45%
Stent Placement
45%
Laparoscopy-assisted
45%
Geriatric Patients
45%
Medicine and Dentistry
Percutaneous Nephrolithotomy
100%
Pyeloplasty
90%
Kidney Stone
75%
Pelvis
72%
Laparoscopic Surgery
71%
Lithotripsy
69%
Adrenalectomy
56%
Adrenal Metastasis
45%
Papillary Renal Cell Carcinomas
45%
Controlled Clinical Trial
45%
Situs Inversus
45%
Nephroureterectomy
45%
Penile prosthesis
45%
Stent Placement
45%
Upper Urinary Tract
45%
Urinary Tract Surgery
45%
Pediatrics Patient
45%
Ureteropelvic Junction Obstruction
45%
Testis Cancer
45%
Patient Satisfaction
45%
Common Bile Duct
45%
Postoperative Pain
45%
Neutrophil
45%
Spinal Anaesthesia
45%
Bupivacaine
45%
Nephrostomy
45%
Holmium
45%
Placebo
45%
Clear Cell Renal Cell Carcinoma
45%
Prostate Cancer
45%
Hyperbilirubinemia
45%
Lymphocyte
45%
Metastatic Carcinoma
43%
Minimally Invasive Procedure
41%
Diseases
36%
Contralateral
34%
Cholestasis
34%
Common Bile Duct Stone
30%
Ureterolithotomy
30%
Erectile Dysfunction
30%
Prosthesis
30%
Anodyne
28%
Operation Duration
26%
Bleeding
26%
Mean Platelet Volume
24%
Primary Tumor
22%
Platelet
20%
Kidney Tumour
20%
Computer Assisted Tomography
20%
Transitional Cell Carcinoma
18%